ArticleFolia microbiologica2026
Determination of phytocompounds and their role in inhibition of efflux pump-related resistance in Pseudomonas aeruginosa PA7.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial Resistance (AMR) remains a global health threat, with efflux pump-based mechanisms being a significant contributor to bacterial drug resistance, highlighting the importance of exploring alternative strategies such as plant-based phytochemicals. Pseudomonas aeruginosa is a pathogen that heavily depends on its Resistance-Nodulation-Division (RND) efflux systems, like MexAB-OprM, as its resistance pathway against antibiotics. By inhibiting these efflux pumps, the pathogen can potentially be susceptible to the same antibiotics it was resistant to. Phytochemicals derived from medicinal plants offer a large scale of bioactive compounds with potential efflux inhibitory properties. However, the inhibitory effects and activity of bioactive compounds from Brassica nigra and Foeniculum vulgare remain largely unexplored, especially with P. aeruginosa. In this study, the crude extracts from mustard and fennel were evaluated for their ability to affect the efflux resistance in P. aeruginosa PA7 (MTCC 1688). Mustard extract demonstrated a stronger inhibitory effect and increased antibiotic susceptibility compared to Fennel extract, which was supported by intracellular accumulation and bacterial growth behaviour. GC-MS profiling helped identify key components of the extract, and molecular docking revealed that mustard-based compounds showed a higher affinity towards the MexB protein. Molecular dynamics simulations further confirmed the stability of compounds from mustard and MexB interactions as potential ligands. Overall, the findings suggest that the mustard phytochemicals may be a promising natural efflux pump inhibitor capable of increasing the potency of antibiotic activity against P.aeruginosa, increasing their relevance in combating AMR.
Indexed as
Identifiers
41545797What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.